Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ensem Therapeutics
Eisai Inc.
PMV Pharmaceuticals, Inc
Mayo Clinic
NiKang Therapeutics, Inc.
Kivu Bioscience Inc.
Alterome Therapeutics, Inc.
Eli Lilly and Company
BeOne Medicines
National Institutes of Health Clinical Center (CC)
Bayer
Genmab
Psyence Australia Pty Ltd
Eli Lilly and Company
Eli Lilly and Company
Terremoto Biosciences Inc.
Jazz Pharmaceuticals
Seagen Inc.
Radiopharm Theranostics, Ltd
Myeloid Therapeutics
Tizona Therapeutics, Inc
AstraZeneca
Normunity AccelCo, Inc.
NiKang Therapeutics, Inc.
IDEAYA Biosciences
MacroGenics
SystImmune Inc.
DualityBio Inc.
Daiichi Sankyo
University of Nebraska
Adela, Inc
Radiopharm Theranostics, Ltd
Eli Lilly and Company
Shanghai Best-Link Bioscience, LLC
Medical College of Wisconsin
Elephas
Mayo Clinic
GlaxoSmithKline
Fate Therapeutics
NextCure, Inc.
Tanabe Pharma America, Inc.
Avenzo Therapeutics, Inc.
Volastra Therapeutics, Inc.
Mersana Therapeutics
LigaChem Biosciences, Inc.
EtiraRx Australia Pty Ltd
858 Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
UNICANCER